Precision 3D Imaging to Monitor Kaposi Sarcoma (KS) with SkinScan3D
Official title: PRecision IMaging to Evaluate Kaposi Sarcoma (PRIME-KS)
Funded at Washington University · NIH-11535366 · Data updated 2026-11-12
A new portable 3D imaging tool called SkinScan3D will help doctors measure KS skin lesions more accurately and quickly, especially in people living with HIV.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | August 7, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $78,512 |
| NIH project number | 3U01CA292765-03S2 |
| Project ID | NIH-11535366 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with Kaposi sarcoma who are receiving treatment and have access to KS lesions suitable for 3D imaging.
✕Less likely to help
Patients with KS lesions not amenable to surface imaging or those unable to participate in imaging workflows may see limited benefit.
What this research studies
KS is an AIDS-defining cancer that is hard to monitor with current methods in busy clinics. This project tests SkinScan3D, a low-cost 3D imaging device with artificial intelligence to measure lesion height and volume. The goal is to provide objective, easy-to-use measurements that could guide treatment decisions without adding substantial clinic time. The study sites include U.S. and East African settings to gather evidence on performance across diverse patient groups.
Why it matters
Potential benefit: If successful, SkinScan3D could make KS monitoring faster and more precise, potentially reducing unnecessary treatments and chemotherapy exposure.
How similar studies have gone: Previous work shows imaging-assisted lesion assessment can improve measurement consistency, but this project tests a novel portable 3D system in KS.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Odeny, Thomas — Washington University
- Study coordinator: Odeny, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Precision 3D Imaging to Track Kaposi Sarcoma (KS) with SkinScan3D
A new 3D imaging tool called SkinScan3D helps doctors monitor Kaposi sarcoma lesions more accurately and quickly, especially in settings with high KS burden like East Africa and in U.S. clinics with HIV patients.
-
Kaposi Sarcoma care and research in Africa during ART era
A collaborative program to better understand and improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV in Zambia and Tanzania.
-
Kaposi Sarcoma in Africa: ART Era Research Network
A collaborative program in Africa and the United States will study Kaposi sarcoma in people living with HIV on ART to improve diagnosis, treatment, and prevention.
-
Kaposi Sarcoma in Africa in the ART Era
This grant supports research to improve how Kaposi sarcoma is detected, treated, and understood in people living with HIV in Zambia and Tanzania during ART, with collaboration between African hospitals and a U.S. center.
-
Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa
This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.
-
Rapid case finding to connect people with HIV and Kaposi sarcoma to care in East Africa
This project works to find people with HIV who develop Kaposi sarcoma more quickly and help them get into medical care sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.